SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-031806
Filing Date
2024-03-07
Accepted
2024-03-07 13:27:20
Documents
1
Period of Report
2024-03-05

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm248239-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm248239-1_4seq1.xml 4 8343
  Complete submission text file 0001104659-24-031806.txt   9845
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Issuer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address DORSET MANAGEMENT CORP 485 UNDERHILL BLVD SUITE 205 SYOSSET NY 11791
Business Address
Sabba Stephen L (Reporting) CIK: 0001442372 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33093 | Film No.: 24729315